Live news related to ABIVAX stock (FR0012333284): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
The stock of French biotech ABIVAX shows a strong increase this afternoon, trading at 109 euros, up 1.68% from the previous close of 107.20 euros. Thi…
Abivax shares saw a significant increase this Monday at midday, rising by 3.75% to €105.00, after closing at €101.20 on Friday. This acceleration exte…
Abivax stock soared this Thursday, March 12, marking an increase of 9.87% to 105.80 euros, while the CAC 40 fell by 0.39% and the SBF 120 dropped 0.34…
Abivax shares fell by 2.11% this Wednesday, reaching €97.20 amidst a general downturn in European markets. The French biotech, which has seen its stoc…
Abivax shares rose by 3.9% this Tuesday at midday, reaching 98.60 euros, after closing at 94.90 euros the previous day. This rebound occurs in a favor…
Abivax experienced a sharp decline this Friday, March 6, closing at €94.20, down 4.94% from the previous day. The French biotech stock has now fallen …
Abivax shares are down 1.89% this Thursday morning, trading at €104.00, continuing a downward trend that began a week ago. The stock of the French bio…
Abivax shares fell by 2.19% this Wednesday morning, trading at 107 euros after closing at 109.40 euros the previous day. This movement occurs in a con…
Abivax shares climbed 2.36% this Tuesday at midday, reaching 112.80 euros. This upward movement follows the presentation of new clinical data on obefa…
At the ECCO 2026 Congress, Abivax presented the first evidence of antifibrotic activity of obefazimod, its therapeutic candidate. The presentation als…
